Not currently recruiting at UC Health
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bayer
- ID
- NCT02576431
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated